Year |
Citation |
Score |
2019 |
Goel A, Nishikawa K, Futaya E, Poylak I, Holt R, Li M, Sagastum E, Marks B, Bossler AD, Johnson FL, Schultz MK, Goda H, Okada H, Orcutt K, Abe G, et al. Abstract LB-230: Quantitative immunohistochemistry for melanocortin 1 receptor using phosphor integrated dots Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Lb-230 |
0.301 |
|
2018 |
Guseva NV, Jaber O, Stence AA, Sompallae K, Bashir A, Sompallae R, Bossler AD, Jensen CS, Ma D. Simultaneous detection of single-nucleotide variant, deletion/insertion, and fusion in lung and thyroid carcinoma using cytology specimen and an RNA-based next-generation sequencing assay. Cancer Cytopathology. PMID 29364576 DOI: 10.1002/Cncy.21963 |
0.305 |
|
2017 |
Ferrand C, Deschamps M, Levitas A, Lockwood C, Payton JE, Uy GL, Schiffer CA, Feldman G, Bossler A, Woolworth J, Mims AS, Shridhar K, Wu N, Huang S, Wei H, et al. Xpert® BCR-ABL Ultra, a High Sensitivity Assay, Demonstrates a Limit of Detection Reaching MR4.5 and below Blood. 130: 1610-1610. DOI: 10.1182/Blood.V130.Suppl_1.1610.1610 |
0.302 |
|
2016 |
Tilak A, Sompallae R, Stence A, Guseva N, Bossler A. Abstract 01: Development of a targeted panel for acute myeloid leukemia (AML) by using next-generation sequencing (NGS) Clinical Cancer Research. 22: 1-1. DOI: 10.1158/1557-3265.Pmsclingen15-01 |
0.328 |
|
2010 |
Harris G, Bossler A. PTPN13 Expression Correlates with Survival in HPV+ HNSCC Otolaryngology–Head and Neck Surgery. 143: P70-P70. DOI: 10.1016/J.Otohns.2010.06.093 |
0.395 |
|
2009 |
Lace MJ, Anson JR, Klingelhutz AJ, Lee JH, Bossler AD, Haugen TH, Turek LP. Human papillomavirus (HPV) type 18 induces extended growth in primary human cervical, tonsillar, or foreskin keratinocytes more effectively than other high-risk mucosal HPVs. Journal of Virology. 83: 11784-94. PMID 19740985 DOI: 10.1128/Jvi.01370-09 |
0.612 |
|
2009 |
Hoover AC, Strand GL, Nowicki PN, Anderson ME, Vermeer PD, Klingelhutz AJ, Bossler AD, Pottala JV, Hendriks WJ, Lee JH. Impaired PTPN13 phosphatase activity in spontaneous or HPV-induced squamous cell carcinomas potentiates oncogene signaling through the MAP kinase pathway. Oncogene. 28: 3960-70. PMID 19734941 DOI: 10.1038/Onc.2009.251 |
0.36 |
|
2009 |
Lace MJ, Anson JR, Klingelhutz AJ, Harada H, Taniguchi T, Bossler AD, Haugen TH, Turek LP. Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1. Carcinogenesis. 30: 1336-44. PMID 19541854 DOI: 10.1093/Carcin/Bgp150 |
0.617 |
|
2009 |
Nowicki P, Hoover A, De Geest K, Goodheart M, Lace M, Haugen T, Turek L, Strand G, Bossler A, Klingelhutz A, Lee J. Protein tyrosine phosphatase nonreceptor 13 (PTPN13) is targeted by human papillomavirus 16 E6 in cervical epithelium Infectious Agents and Cancer. 4. DOI: 10.1186/1750-9378-4-S2-P31 |
0.593 |
|
2009 |
Hoover A, Strand G, Nowicki P, Anderson M, Klingelhutz A, Bossler A, Lee J. An invasion mechanism for human papillomavirus related cancers: HPV 16 E6 degrades PTPN13 allowing enhanced map kinase signaling Infectious Agents and Cancer. 4: 1-1. DOI: 10.1186/1750-9378-4-S2-O13 |
0.423 |
|
2008 |
Spanos WC, Hoover A, Harris GF, Wu S, Strand GL, Anderson ME, Klingelhutz AJ, Hendriks W, Bossler AD, Lee JH. The PDZ binding motif of human papillomavirus type 16 E6 induces PTPN13 loss, which allows anchorage-independent growth and synergizes with ras for invasive growth. Journal of Virology. 82: 2493-500. PMID 18160445 DOI: 10.1128/Jvi.02188-07 |
0.412 |
|
2008 |
Spanos WC, Geiger J, Anderson ME, Harris GF, Bossler AD, Smith RB, Klingelhutz AJ, Lee JH. Deletion of the PDZ motif of HPV16 E6 preventing immortalization and anchorage-independent growth in human tonsil epithelial cells. Head & Neck. 30: 139-47. PMID 17657785 DOI: 10.1002/Hed.20673 |
0.429 |
|
Show low-probability matches. |